| ID | Type | Location (GRCh37) | Location (GRCh38) | Length | GC content |
|---|---|---|---|---|---|
| hsa_chr7_0100200 | Intergenic-Intergenic | chr7:122293048-122293392 | chr7:122652994-122653338 | 345 nt | 0.4696 |
| hsa_CADPS2_0018700 | Exon-Exon | chr7:122303291-122303623 | chr7:122663237-122663569 | 333 nt | 0.4144 |
| hsa_CADPS2_0018500 | Intron-Exon-Intron | chr7:122303291-122342369 | chr7:122663237-122702315 | 250 nt | 0.3240 |
| hsa_CADPS2_0018800 | Exon-Exon | chr7:122303291-122377122 | chr7:122663237-122737068 | 120 nt | 0.4417 |
| hsa_CADPS2_0018600 | Intron-Exon-Intron | chr7:122303291-122429184 | chr7:122663237-122789130 | 250 nt | 0.3400 |
| hsa_CADPS2_0018900 | Exon-Exon | chr7:122303335-122303492 | chr7:122663281-122663438 | 158 nt | 0.4241 |
| hsa_CADPS2_0019000 | Intron-Intron | chr7:122353000-122353426 | chr7:122712946-122713372 | 427 nt | 0.3419 |
| hsa_CADPS2_0019100 | Intron-Exon-Intron | chr7:122370030-122377122 | chr7:122729976-122737068 | 114 nt | 0.4386 |
| hsa_chr7_0100300 | Intergenic-Intergenic | chr7:122372294-122372689 | chr7:122732240-122732635 | 396 nt | 0.2803 |
| hsa_CADPS2_0019200 | Intron-Exon-Intron | chr7:122374823-122377122 | chr7:122734769-122737068 | 114 nt | 0.4386 |
A review of studies in humans, mice, and rats indicates that the circCADPS2 demonstrates stable expression in myocardial tissue and body fluids, with specific expression patterns associated with sudden cardiac death-related diseases [Tian et al. DOI:10.3390/molecules26041155]. A study in human traumatic brain injury (TBI) patients identified the circCADPS2 as a top up-regulated circular RNA (fold change 17.62) in brain injury tissues compared to adjacent contusion tissues, with its increased expression validated by qRT-PCR [Li et al. DOI:10.3389/fneur.2022.1086553].